{
    "SPADE_UN_11980": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_UN_11980",
            "Peptide Name": "PV (Derived from pEM-2 and MP-VT1)",
            "Source": "Synthetic construct",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "KKWRWWLKALAKKLL",
            "Sequence Length": 15,
            "UniProt Entry": "No entry found",
            "Protein Existence": "Synthetic form",
            "Biological Activity": [
                "Antimicrobial",
                "Antibacterial",
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "[Ref.27591703] Gram-positive bacteria :Staphylococcus aureus isolates(MIC=0.5 ± 0.0 mg/L, MBC=0.5 ± 0.0 mg/L), Enterococcus faecalis isolates(MIC=0.7 ± 0.3 mg/L, MBC=0.8 ± 0.3 mg/L);Gram-negative bacteria :Pseudomonas aeruginosa isolates(MIC=1.2 ± 0.8 mg/L, MBC=1.3 ± 0.6 mg/L), Acinetobacter baumannii isolates(MIC=0.4 ± 0.1 mg/L, MBC=0.5 ± 0.0 mg/L)",
            "Hemolytic Activity": "[Ref.27591703] 0% hemolysis at 32 μg/ml , 5% hemolysis at 64 μg/ml against human red blood cells; 0% hemolysis at 32 μg/ml , 8% hemolysis at 64 μg/ml against sheep red blood cells",
            "Cytotoxicity": "[Ref.27591703] The cell viability of HEK293 cells induced by PV is 98.8%, 97.4%, 85.8%, 56.2%, 22.8%, 12.2% and 2.3% at peptide concentrations of 1, 2, 4, 8, 16, 32, 64 μg/mL within 24h.",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Linear",
            "N-terminal Modification": "Free",
            "C-terminal Modification": "Amidation",
            "Stereochemistry": "L",
            "Structure Description": "Not found",
            "Formula": "C99H158N26O16",
            "Mass": 1968.48,
            "PI": 11.39,
            "Net Charge": 6,
            "Hydrophobicity": -0.53,
            "Half Life": "Mammalian:1.3 hourYeast:3 minE.coli:2 min",
            "Function": "Antibacterial activity against Gram-positive bacteria and Gram-negative bacteria",
            "Literature": [
                {
                    "Title": "Design and characterization of short hybrid antimicrobial peptides from pEM-2, mastoparan-VT1, and mastoparan-B.",
                    "Pubmed ID": "27591703",
                    "Reference": "Chem Biol Drug Des. 2017 Mar;89(3)327-338. doi 10.1111/cbdd.12864.",
                    "Author": "Memariani H, Shahbazzadeh D, Ranjbar R, Behdani M, Memariani M, Pooshang Bagheri K",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=27591703"
                },
                {
                    "Title": "Rational Evolution of Antimicrobial Peptides Containing Unnatural Amino Acids to Combat Burn Wound Infections",
                    "Pubmed ID": "",
                    "Author": "Xiong M, Chen M, Zhang J"
                }
            ],
            "Frequent Amino Acids": "KLW",
            "Absent Amino Acids": "CDEFGHIMNOPQSTUVY",
            "Basic Residues": 6,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 9,
            "Polar Residues": 8,
            "Positive Residues": 6,
            "Negative Residues": 0,
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_00601",
                    "Similarity": 1.0,
                    "Sequence": "WLKKW"
                },
                {
                    "SPADE_ID": "SPADE_UN_05408",
                    "Similarity": 1.0,
                    "Sequence": "RLKRRKKWR"
                },
                {
                    "SPADE_ID": "SPADE_UN_11979",
                    "Similarity": 1.0,
                    "Sequence": "KKWRWWLKALAKK"
                }
            ]
        }
    }
}